AEON Biopharma, Inc. (AEON) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.91M |
| Enterprise Value | 43.65M |
| P/E Ratio | -0.13 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -0.48 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.17 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -6.97 |
| Return On Equity | 2.24 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -16.22M |
| Net Income | -39.22M |
| Diluted EPS | -3.95 |
Balance Sheet
| Total Cash | 6.24M |
| Total Cash/Share | 0.52 |
| Total Debt | 2.63M |
| Total Debt/Equity | -0.16 |
| Current Ratio | 0.99 |
| Book Value Per Share | -1.38 |
Price History
| 52-Week Change | -6.76 |
| 52-Week High | 1.45 |
| 52-Week Low | 0.51 |
| Moving Average 50 Days | 0.84 |
| Moving Average 200 Days | 0.95 |
Statistics
| Average Volume | 90,124 |
| Shares Outstanding | 11.83M |
| % Held by Institutions | 28.64 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:72 |
| Last Split Date | February 26, 2025 |
AD
